Hospital-onset clostridium difficile infection rates in persons with cancer or Hematopoietic stem cell transplant: A C3IC network report

  • Mini Kamboj
  • , Crystal Son
  • , Sherry Cantu
  • , Roy F. Chemaly
  • , Jeanne Dickman
  • , Erik Dubberke
  • , Lisa Engles
  • , Theresa Lafferty
  • , Gale Liddell
  • , Mary Ellen Lesperance
  • , Julie E. Mangino
  • , Stacy Martin
  • , Jennie Mayfield
  • , Sapna A. Mehta
  • , Susan O'Rourke
  • , Cheryl S. Perego
  • , Randy Taplitz
  • , Janet Eagan
  • , Kent A. Sepkowitz

Research output: Contribution to journalArticlepeer-review

Abstract

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HOCDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

Original languageEnglish
Pages (from-to)1162-1164
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume33
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Dive into the research topics of 'Hospital-onset clostridium difficile infection rates in persons with cancer or Hematopoietic stem cell transplant: A C3IC network report'. Together they form a unique fingerprint.

Cite this